SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-23-039334
Filing Date
2023-11-03
Accepted
2023-11-03 16:49:20
Documents
14
Period of Report
2023-09-17
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm   iXBRL 8-K/A 63771
2 ex23-1.htm EX-23.1 4599
  Complete submission text file 0001493152-23-039334.txt   292532

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biaf-20230917.xsd EX-101.SCH 3785
4 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT biaf-20230917_def.xml EX-101.DEF 26626
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biaf-20230917_lab.xml EX-101.LAB 36673
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biaf-20230917_pre.xml EX-101.PRE 25250
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-ka_htm.xml XML 5414
Mailing Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257
Business Address 22211 WEST INTERSTATE-10 SUITE 1206 SAN ANTONIO TX 78257 210-698-5334
bioAffinity Technologies, Inc. (Filer) CIK: 0001712762 (see all company filings)

IRS No.: 465211056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-41463 | Film No.: 231377077
SIC: 8731 Services-Commercial Physical & Biological Research